Changes in Serum Cytokine Levels in Active Tuberculosis With Treatment

Raras, T. Y. M., Astuti, T., & Chozin, I. N. (2012). Soluble Urokinase Plasminogen Activator Receptor Levels in Tuberculosis Patients at High Risk for Multidrug Resistance. Tuberculosis Research and Treatment, 2012(), 37-41. https://doi.org/10.1155/2012/240132
Vesenbeckh, S. M., Schönfeld, N., Mauch, H., Bergmann, T., Wagner, S., Bauer, T. T., & Rüssmann, H. (2012). The Use of Interferon Gamma Release Assays in the Diagnosis of Active Tuberculosis. Tuberculosis Research and Treatment, 2012(), 106-109. https://doi.org/10.1155/2012/768723
Wieczorek, A., & Uharek, L. (2015). Management of Chronic Myeloid Leukemia Patients Resistant to Tyrosine Kinase Inhibitors Treatment. Biomarker Insights, 2015(S3), 49-54. https://doi.org/10.4137/BMI.S22431
Lu, C. C., & Lai, H. C. (2008). Current Dilemma and Developments in the Diagnosis of Mycobacterium tuberculosis Infection. Journal of the Formosan Medical Association, 107(5), 353-354. https://www.airitilibrary.com/Article/Detail?DocID=09296646-200805-107-5-353-354-a
蔡麗玉、江季勛、劉武哲、陳瑞三（1985）。Studies on the Serum DNA Polymerase in Leukemic Patients。The Kaohsiung Journal of Medical Sciences，1(9)，571-578。https://doi.org/10.6452/KJMS.198509.0571